Transferrin C subtypes and myocardial infarction.
Transferrin C subtypes were studied in 124 patients who were survivors of myocardial infarction and population controls to test the hypothesis that the TFC2 type is associated with an increased risk for myocardial infarction. The TFC2 type showed, however, only a marginal increase among the patients (p = 0.038), whereas the TF*C3 allele (p = 0.0004) and the types carrying the TFC3 variant, TFC3-1 and C3-2, displayed a highly significant increase (p = 0.0002).